Danish pharmaceutical multinational Novo Nordisk is expanding its presence in inherited blood disorder treatments ...

Many doctors agree with the Food and Drug Administration’s recent decision to remove the black box warnings on at least some ...

Researchers report links between third-trimester exposure to endocrine disruptors and higher behavioural risk scores in early childhood.

A study led by biomedical scientists at the University of California, Riverside, has shown for the first time that a father’s ...

Get the live share price of Viking Therapeutics Inc (VKTX), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

At the San Antonio Breast Cancer Symposium, investigators reported phase III results showing that the oral selective estrogen ...

The rare diseases treatment market is entering a pivotal phase marked by advanced therapeutic innovation, multi-stakeholder collaboration, and fundamental changes to research and ...

Menopause represents a profound systemic shift involving cardiovascular, skeletal, and neurological health, requiring ...

Following the success of the initial collection, we are pleased to present a second volume of the Research Topic, “Endocrine Insights into Heart Disease.”It ...